跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Latadin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Latadin
Approved
STANDARD
Latadin
Egyptian International Pharmaceutical Industries Co.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7c3a9c25024c83bd
Company
Egyptian International Pharmaceutical Industries Co.
Type
Standard
Approval Details
Approval Id
7c3a9c25024c83bd
Drug Approval Philippines Name
Latadin
Product Name
Latadin
Registration Number
DRP-8046-01
Brand Name
Latadin
Generic Name
Latanoprost
Dosage Form
Sterile Ophthalmic Solution (Eye Drops)
Dosage Strength
50 mcg/mL (0.005% w/v)
Manufacturer
Egyptian International Pharmaceutical Industries Co.
Importer
Ambica International Corporation
Distributor
Medchoice Vision Care Inc.
Issuance Date
24 October 2022
Expiry Date
05 December 2028
Pharmacologic Category
Prostaglandin Analogue (Antiglaucoma)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7c3a9c25024c83bd
Type
Standard
Back to Philippines FDA Approvals